<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochemistry</journal-id><journal-id journal-id-type="iso-abbrev">Biochemistry</journal-id><journal-id journal-id-type="publisher-id">bi</journal-id><journal-id journal-id-type="coden">bichaw</journal-id><journal-title-group><journal-title>Biochemistry</journal-title></journal-title-group><issn pub-type="ppub">0006-2960</issn><issn pub-type="epub">1520-4995</issn><publisher><publisher-name>American
Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28425697</article-id><article-id pub-id-type="pmc">5467178</article-id><article-id pub-id-type="doi">10.1021/acs.biochem.7b00179</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Conserved Helix-Flanking Prolines Modulate Intrinsically
Disordered Protein:Target Affinity by Altering the Lifetime of the
Bound Complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Crabtree</surname><given-names>Michael
D.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Borcherds</surname><given-names>Wade</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Poosapati</surname><given-names>Anusha</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><name><surname>Shammas</surname><given-names>Sarah L.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="notes-1" ref-type="notes">&#x02225;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Daughdrill</surname><given-names>Gary W.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath6"><name><surname>Clarke</surname><given-names>Jane</given-names></name><xref rid="cor3" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Chemistry, <institution>University of Cambridge</institution>, Cambridge CB2 1EW, <country>U.K.</country></aff><aff id="aff2"><label>&#x02021;</label>Department
of Cell Biology, Microbiology and Molecular Biology, <institution>University of South Florida</institution>, Tampa, Florida 33620, <country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label>Florida
Center for Drug Discovery and Innovation, <institution>University of South Florida</institution>, Tampa, Florida 33612, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>E-mail: <email>sarah.shammas@bioch.ox.ac.uk</email>.</corresp><corresp id="cor2"><label>*</label>E-mail: <email>gdaughdrill@usf.edu</email>.</corresp><corresp id="cor3"><label>*</label>E-mail: <email>jc162@cam.ac.uk</email>.</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>04</month><year>2017</year></pub-date><pub-date pub-type="ppub"><day>09</day><month>05</month><year>2017</year></pub-date><volume>56</volume><issue>18</issue><fpage>2379</fpage><lpage>2384</lpage><history><date date-type="received"><day>02</day><month>03</month><year>2017</year></date><date date-type="rev-recd"><day>13</day><month>04</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 American Chemical Society</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Attribution (CC-BY) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html">License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_0005" id="ab-tgr1"/></p><p>Appropriate
integration of cellular signals requires a delicate
balance of ligand&#x02013;target binding affinities. Increasing the
level of residual structure in intrinsically disordered proteins (IDPs),
which are overrepresented in these cellular processes, has been shown
previously to enhance binding affinities and alter cellular function.
Conserved proline residues are commonly found flanking regions of
IDPs that become helical upon interacting with a partner protein.
Here, we mutate these helix-flanking prolines in p53 and MLL and find
opposite effects on binding affinity upon an increase in free IDP
helicity. In both cases, changes in affinity were due to alterations
in dissociation, not association, rate constants, which is inconsistent
with conformational selection mechanisms. We conclude that, contrary
to previous suggestions, helix-flanking prolines do not regulate affinity
by modulating the rate of complex formation. Instead, they influence
binding affinities by controlling the lifetime of the bound complex.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>bi7b00179</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>bi-2017-00179h</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">Intrinsically
disordered proteins
(IDPs) or intrinsically disordered regions of proteins (IDRs) lack
a well-defined three-dimensional fold and exist as ensembles of conformations
with variable levels of transient structure.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> A subset of IDRs fold upon binding to their partner macromolecule.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> For IDRs that form &#x003b1;-helices upon coupled
folding and binding, increasing the residual helicity of the free
IDR has been shown to increase the affinity for the partner protein.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> Conserved proline residues are commonly found flanking transiently
helical binding segments of IDRs<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). The abundance and conservation of helix-flanking
prolines in IDPs point toward an important biological function. Proline
residues are known helix breakers, and these conserved helix-flanking
prolines may act to restrict the transient residual helicity of the
free IDR<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> and consequently the affinity for the partner
protein. We have previously shown that this is the case for the disordered
transactivation domain of p53, where mutation of conserved helix-flanking
prolines increases the peak residual helicity of the free state by
approximately 40%.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> When the proline 27
to alanine (P27A) mutation is present, this increase in residual helicity
is accompanied by a 10-fold increase in affinity for its ordered binding
partner, MDM2.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Position and conservation of helix-flanking prolines in
IDRs. Bound
structures of IDPs/IDRs that undergo coupled folding and binding to
form &#x003b1;-helices that are flanked by prolines. From top to bottom:
p53:MDM2 [Protein Data Bank (PDB) entry 1YCR], MLL:CBP KIX (PDB entry 2LXS), c-Myb:CBP KIX
(PDB entry 1SB0), CREB:CBP KIX (PDB entry 1KDX), SHP-1:SF-1 (PDB entry 1YMT), and PGC-1 &#x003b1;:PPAR&#x003b3; (PDB
entry 3CS8),
respectively. Folded partner proteins are colored gray and IDPs and
IDRs red. Helix-flanking prolines are represented as cyan spheres.
Cyan circles indicate helix-flanking prolines that are not present
in the structure. N denotes the N-terminus of the IDP/IDR. For each
IDP/IDR, the sequences from <italic>Homo sapiens</italic>, <italic>Mus musculus</italic>, <italic>Gallus gallus</italic>, and <italic>Danio rerio</italic> were aligned using Clutsal Omega.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> The p53 alignment is from ref (<xref ref-type="bibr" rid="ref3">3</xref>). The peptide region used in the structure is highlighted
in gray, with residues that form &#x003b1;-helices upon binding highlighted
in red. Helix-flanking prolines are highlighted. As determined with
Clustal Omega, positions of full residue conservation are indicated
with an asterisk, a colon indicates conservation of strongly similar
amino acid properties, and weakly similar properties are specified
with a period.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_0001" id="gr1" position="float"/></fig><p>It has been suggested
that observing a concomitant enhancement
in IDR residual helicity and IDR:target partner protein affinity,
will lead to an increase in the proportion of binding competent species
within the conformational ensemble and, thus, an increase in the rate
of complex formation.<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> However, kinetic information is
required to justify such mechanistic conclusions.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> Here
we determine the mechanism behind the increase in the affinity of
p53 for MDM2 upon proline to alanine mutation (PtoA). We then investigate
helix-flanking prolines in the transactivation domain of MLL, another
IDR, to determine the commonality of this mechanism. We demonstrate
that the principal effect is on complex lifetime, rather than rate
of formation, but that conserved helix-flanking prolines have more
subtlety in the way that they can control affinity than a simple model
might predict.</p><sec id="sec2"><title>Materials and Methods</title><p>Methods for
protein expression, purification and labeling, circular
dichroism, and equilibrium binding experiments are described in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Supporting Information</ext-link>.</p><sec id="sec2.1"><title>Peptides</title><p>MLL peptides
were synthesized by Biomatik
and purchased as trifluoroacetate salts with a fluorescein isothiocyanate
(FITC)-labeled or free N-terminus. Wild-type (WT) MLL consisted of
31 amino acids: residues 2838&#x02013;2869 (Uniprot entry Q03164) with
residue C2841 removed to avoid disulfide bond formation. p53 peptides
were produced recombinantly and labeled with Alexa Fluor dyes, as
described in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Supporting Information</ext-link>.</p></sec><sec id="sec2.2"><title>Biophysical Buffer</title><p>Biophysical buffer for p53 and MDM2
consisted of 50 mM sodium phosphate, 100 mM NaCl, 1 mM EDTA, 2 mM
DTT, and 0.02% sodium azide (pH 6.8). Biophysical buffer for MLL and
KIX consisted of 100 mM sodium phosphate and 0.05% Tween 20 (pH 7.4).</p></sec><sec id="sec2.3"><title>Nuclear Magnetic Resonance (NMR) Data Collection and Analysis</title><p>NMR experiments for WT MLL and the P9/21A mutant were performed
using uniformly <sup>15</sup>N- and <sup>13</sup>C-labeled samples
at 160 and 155 &#x003bc;M, respectively, at 10 &#x000b0;C on a Varian VNMRS
800 MHz spectrometer equipped with a triple-resonance pulse field <italic>Z</italic>-axis gradient cold probe. To make the amide <sup>1</sup>H and <sup>15</sup>N as well as <sup>13</sup>C<sub>&#x003b1;</sub>, <sup>13</sup>C<sub>&#x003b2;</sub>, and <sup>13</sup>CO resonance assignments,
sensitivity-enhanced <sup>1</sup>H&#x02013;<sup>15</sup>N HSQC and
three-dimensional HNCACB and HNCO experiments were performed on the
uniformly <sup>15</sup>N- and <sup>13</sup>C-labeled samples in 90%
H<sub>2</sub>O/10% D<sub>2</sub>O, 50 mM phosphate buffer with 50
mM NaCl, 1 mM EDTA, and 0.02% NaN<sub>3</sub> (pH 6.8). For the HNCACB
experiment, data were acquired in the <sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N dimensions using 9689.9 (<italic>t</italic><sub>3</sub>) Hz &#x000d7; 14074.1 (<italic>t</italic><sub>2</sub>)
Hz &#x000d7; 1944.5 (<italic>t</italic><sub>1</sub>) Hz sweep widths
and 1024 (<italic>t</italic><sub>3</sub>) &#x000d7; 128 (<italic>t</italic><sub>2</sub>) &#x000d7; 32 (<italic>t</italic><sub>1</sub>) complex
data points. For the HNCO, the sweep widths were 9689.9 (<italic>t</italic><sub>3</sub>) Hz &#x000d7; 3770.1 (<italic>t</italic><sub>2</sub>) Hz
&#x000d7; 1944.5 (<italic>t</italic><sub>1</sub>) Hz, and complex data
points were identical to those of the HNCACB.<sup><xref ref-type="bibr" rid="ref13">13</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref></sup> The sweep widths
and complex points of the HSQC were 9689.9 (<italic>t</italic><sub>2</sub>) Hz &#x000d7; 1944.5 (<italic>t</italic><sub>1</sub>) Hz and
1024 (<italic>t</italic><sub>2</sub>) &#x000d7; 128 (<italic>t</italic><sub>1</sub>), respectively. For WT MLL, processing and analysis
of the HNCACB data resulted in 28 non-proline, amide <sup>1</sup>H, <sup>15</sup>N, <sup>13</sup>C<sub>&#x003b1;</sub>, and 26 <sup>13</sup>C<sub>&#x003b2;</sub> resonance assignments and three proline <sup>13</sup>C<sub>&#x003b1;</sub> and <sup>13</sup>C<sub>&#x003b2;</sub> resonance
assignments. Twenty-seven <sup>13</sup>CO resonance assignments were
made using the HNCO data. For mutant MLL, processing and analysis
of the HNCACB data resulted in 30 non-proline, amide <sup>1</sup>H, <sup>15</sup>N, <sup>13</sup>C<sub>&#x003b1;</sub>, and 28 <sup>13</sup>C<sub>&#x003b2;</sub> resonance assignments and one proline <sup>13</sup>C<sub>&#x003b1;</sub> and <sup>13</sup>C<sub>&#x003b2;</sub> resonance
assignment. Twenty-nine <sup>13</sup>CO resonance assignments were
made using the HNCO data.</p><p>All NMR spectra were processed with
NVFx and analyzed using nmrViewJ.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> Apodization
was achieved in the <sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N dimensions using a squared sine bell function shifted by 70&#x000b0;.
Apodization was followed by zero filling to double the number of real
data points, and linear prediction was used in the <sup>15</sup>N
dimension. The <sup>1</sup>H carrier frequency was set on 4,4-dimethyl-4-silapentane-1-sulfonic
acid (DSS was used as the reference frequency).<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Secondary chemical shift values were calculated by subtracting
the residue specific random coil chemical shifts in the neighbor-corrected
IDP chemical shift library (ncIDP) from the measured chemical shifts.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Secondary structure populations were calculated
with d2D using the measured proton, nitrogen, and &#x003b1;, &#x003b2;,
and carbonyl carbon chemical shifts.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The
overall helicity was calculated as the mean of the per residue d2D
helical population estimates.</p></sec><sec id="sec2.4"><title>Binding Kinetics</title><p>Binding kinetics were followed using
SX18 or SX20 stopped-flow spectrometers (Applied Photophysics). Temperatures
were maintained at 25 or 5 &#x000b0;C for p53:MDM2 or MLL:KIX, respectively.
The lower temperatures were required to follow the fast observed rates
of MLL:KIX. Excitation wavelengths of 493 and 593 nm were used in
conjunction with 515 and 610 nm long pass filters, respectively. Data
within the dead time of mixing (the first 1 ms) were removed before
fitting.</p><p>Association experiments were performed under pseudo-first-order
conditions, such that the concentration of the partner protein was
at least 10-fold higher than the concentration of the peptide. For
each concentration of excess protein, 30&#x02013;70 traces for p53
were collected and averaged. Kinetic traces were fit to a single-exponential
decay function to extract observed association rate constants (<italic>k</italic><sub>obs</sub>). Association rate constants (<italic>k</italic><sub>on</sub>) were obtained from the gradient of the straight line
fit of the observed rate versus the concentration of excess protein
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figures S1a and S3b</ext-link>).</p><p>For dissociation
experiments, 0.25&#x02013;0.5 &#x003bc;M labeled
peptide was pre-equilibrated with 1&#x02013;2.5 &#x003bc;M partner protein
and mixed with various concentrations (0&#x02013;50 &#x003bc;M) of unlabeled
ligand. Kinetic traces were fit to a single-exponential decay function
to extract <italic>k</italic><sub>obs</sub>. p53 P27A (Alexa 594-labeled)
fit poorly to a single exponential and was instead fit to a double-exponential
function. Two dissociation rates were also observed with p53 P27A
labeled with another dye, Alexa 488, suggesting dye-specific causes
were not responsible for the observed biphasic dissociation kinetics.
The most likely explanation is therefore that p53 P27A follows a three-state
reaction, as discussed in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>. We note that WT p53 may also follow this pathway,
but with rates or amplitudes that cannot be detected by stopped-flow
methods. We note that this does not affect our conclusions. Dissociation
rate constants (<italic>k</italic><sub>off</sub>) were obtained either
from the fit of dissociation <italic>k</italic><sub>obs</sub>, as
a function of the unlabeled ligand concentration, as described previously,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> or from the mean of the <italic>k</italic><sub>obs</sub> obtained at concentrations of competing peptide at which <italic>k</italic><sub>obs</sub> was essentially concentration-independent,
as described previously.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Observed rate constants
for the interaction between p53 and MDM2.
(A) Observed rate constants (<italic>k</italic><sub>obs</sub>) from
pseudo-first-order association binding experiments, with MDM2 in excess.
The association rate constant (<italic>k</italic><sub>on</sub>) is
given by the gradient of the straight line fit. (B) Dissociation <italic>k</italic><sub>obs</sub> from competition dissociation studies. Biphasic
dissociation kinetics for p53 P27A may be due to either the presence
of an intermediate on the dissociation pathway or a secondary binding
event. The dissociation rate constant (<italic>k</italic><sub>off</sub>) is given by the asymptote. Error bars, representing the error of
the fit, are smaller than the data points.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_0002" id="gr2" position="float"/></fig></sec><sec id="sec2.5"><title>Fitting MLL P9/20A and L8A Binding Kinetics</title><p>Between
60 and 120 traces were collected for each concentration of excess
partner protein/peptide. Each trace was individually fit to a single-exponential
decay function. The individual rate constants obtained for single
traces (at each concentration of excess partner protein) were plotted
as histograms and fit to a Gaussian function (<xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>) to extract an average rate:<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_m001" position="anchor"/><label>1</label></disp-formula>where <italic>a</italic> is a scaling constant,
&#x003bc; is the mean, and &#x003c3; is the standard deviation.</p><p>To assist Gaussian fitting, only individual fitted rates between
0 and 1000 s<sup>&#x02013;1</sup> were included: rates below 0 s<sup>&#x02013;1</sup> have no physical meaning, and rates above 1000 s<sup>&#x02013;1</sup> cannot be feasibly detected with the stopped-flow
setup used to collect these data.</p><p>To uncover and minimize any
potential dependence of the extracted
rate on the chosen bin size, 10 bin sizes (from 5 to 50 in increments
of 5) were used to generate histograms. <italic>k</italic><sub>obs</sub> was determined as the mean &#x003bc; over all bin sizes. <italic>k</italic><sub>on</sub> was obtained from the gradient of the straight line
fit of <italic>k</italic><sub>obs</sub> versus partner protein concentration.
Dissociation <italic>k</italic><sub>obs</sub> values at each concentration
of excess peptide were determined as described above. <italic>k</italic><sub>off</sub> was then obtained by taking the mean of dissociation <italic>k</italic><sub>obs</sub> at different concentrations of out-competitor.</p><p>These described data analyses for MLL P9/20A and L8 were performed
using a bespoke script created in Mathematica (Wolfram).</p></sec></sec><sec id="sec3"><title>Results
and Discussion</title><p>Using stopped-flow fluorescence, we investigated
the kinetic basis
for the increase in affinity of p53 for MDM2, upon mutation of helix-flanking
prolines to alanine (PtoA). If the increased level of residual structure
increased the proportion of binding competent p53, i.e., a conformational
selection mechanism, the PtoA mutations would be expected to increase
the association rate constant (<italic>k</italic><sub>on</sub>), yet
despite increasing the residual helicity within the region that becomes
helical upon binding by 2.5-fold,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> an only
1.23 &#x000b1; 0.06-fold increase in <italic>k</italic><sub>on</sub> (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A) was observed for
the P27A mutant. Clearly, an enhanced rate of complex formation does
not therefore explain the 10-fold increase in affinity for p53 P27A.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> All other p53 proline to alanine (PtoA) mutants
displayed similarly small changes in <italic>k</italic><sub>on</sub> (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Two dissociation
rate constants (<italic>k</italic><sub>off</sub>) were observed for
the P27A p53 mutant compared to one for WT p53 (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). An approximate 12-fold reduction in <italic>k</italic><sub>off</sub> was observed for the faster of the two rates,
while the slower rate was around 60-fold lower than that of the WT
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). Thus,
the PtoA mutation increases the stability of p53:MDM2 by reducing
the dissociation rate constant, suggesting that the influence of conserved
helix-flanking prolines is on the stability of the bound complex.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Peptide Helicities and Equilibrium
and Rate Constants<xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="char" char="&#x000b1;"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">peptide</th><th style="border:none;" align="center">helicity (NMR) (%)</th><th style="border:none;" align="center">helicity (CD) (%)</th><th style="border:none;" align="center" char="&#x000b1;">equilibrium <italic>K</italic><sub>d</sub> (nM)</th><th style="border:none;" align="center">kinetic <italic>K</italic><sub>d</sub> (nM)</th><th style="border:none;" align="center"><italic>k</italic><sub>on</sub> (&#x000d7;10<sup>6</sup>&#x000a0;M<sup>&#x02013;1</sup>&#x000a0;s<sup>&#x02013;1</sup>)</th><th style="border:none;" align="center"><italic>k</italic><sub>off</sub> (s<sup>&#x02013;1</sup>)</th></tr></thead><tbody><tr><td style="border:none;" align="left">p53 WT</td><td style="border:none;" align="left">3</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="char" char="&#x000b1;">240&#x000a0;&#x000b1;&#x000a0;60</td><td style="border:none;" align="left">176&#x000a0;&#x000b1;&#x000a0;8</td><td style="border:none;" align="left">25&#x000a0;&#x000b1;&#x000a0;1</td><td style="border:none;" align="left">4.40&#x000a0;&#x000b1;&#x000a0;0.03</td></tr><tr><td style="border:none;" align="left">p53 P27A</td><td style="border:none;" align="left">6</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="char" char="&#x000b1;">25&#x000a0;&#x000b1;&#x000a0;3</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">30.7&#x000a0;&#x000b1;&#x000a0;0.7</td><td style="border:none;" align="left">fast, 0.37&#x000a0;&#x000b1;&#x000a0;0.01</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="char" char="&#x000b1;">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">slow, 0.072&#x000a0;&#x000b1;&#x000a0;0.005</td></tr><tr><td style="border:none;" align="left">p53 P12/13A</td><td style="border:none;" align="left">3</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="char" char="&#x000b1;">220&#x000a0;&#x000b1;&#x000a0;30</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">22&#x000a0;&#x000b1;&#x000a0;2</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td></tr><tr><td style="border:none;" align="left">p53 P12/13/27A</td><td style="border:none;" align="left">6</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="char" char="&#x000b1;">17&#x000a0;&#x000b1;&#x000a0;6</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">32.4&#x000a0;&#x000b1;&#x000a0;0.9</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td></tr><tr><td style="border:none;" align="left">MLL WT</td><td style="border:none;" align="left">2</td><td style="border:none;" align="left">13</td><td style="border:none;" align="char" char="&#x000b1;">660&#x000a0;&#x000b1;&#x000a0;60</td><td style="border:none;" align="left">530&#x000a0;&#x000b1;&#x000a0;30</td><td style="border:none;" align="left">24&#x000a0;&#x000b1;&#x000a0;1</td><td style="border:none;" align="left">12.4&#x000a0;&#x000b1;&#x000a0;0.3</td></tr><tr><td style="border:none;" align="left">MLL P21A</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">14</td><td style="border:none;" align="char" char="&#x000b1;">700&#x000a0;&#x000b1;&#x000a0;120</td><td style="border:none;" align="left">560&#x000a0;&#x000b1;&#x000a0;15</td><td style="border:none;" align="left">22.0&#x000a0;&#x000b1;&#x000a0;0.6</td><td style="border:none;" align="left">12.22&#x000a0;&#x000b1;&#x000a0;0.08</td></tr><tr><td style="border:none;" align="left">MLL P9/21A</td><td style="border:none;" align="left">3</td><td style="border:none;" align="left">16</td><td style="border:none;" align="char" char="&#x000b1;">17000&#x000a0;&#x000b1;&#x000a0;2000</td><td style="border:none;" align="left">9000&#x000a0;&#x000b1;&#x000a0;6000</td><td style="border:none;" align="left">20&#x000a0;&#x000b1;&#x000a0;14</td><td style="border:none;" align="left">200&#x000a0;&#x000b1;&#x000a0;16</td></tr><tr><td style="border:none;" align="left">MLL L8A</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">12</td><td style="border:none;" align="char" char="&#x000b1;">35000&#x000a0;&#x000b1;&#x000a0;4000</td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">nd<xref rid="tbl1-fn1" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">170&#x000a0;&#x000b1;&#x000a0;14</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>The percent helicity values reported
in this table were calculated as described in <xref rid="sec2" ref-type="other">Materials
and Methods</xref> and represent the change across the entire peptide
sequence. Overall changes in helicity are predominantly due to increased
helicity within the binding region (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Errors for equilibrium <italic>K</italic><sub>d</sub> measurements represent the standard error of the mean
(SEM; <italic>n</italic> = 3). Errors for rate constants represent
the error of the fit, except for MLL P9/21A and MLL L8A, where the
error represents the SEM (<italic>n</italic> = 7 and 5, respectively).
Kinetic <italic>K</italic><sub>d</sub> was calculated as <italic>k</italic><sub>off</sub>/<italic>k</italic><sub>on</sub>, with the errors propagated
using standard methods. Data for p53 equilibrium <italic>K</italic><sub>d</sub> and helicity (NMR) were taken from ref (<xref ref-type="bibr" rid="ref3">3</xref>). A recent mutational analysis
of MLL showed that the equivalent leucine to alanine mutation (L8A)
was stabilizing at pH 4,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> although the
authors could not measure the effects at pH 7.2 and noted that several
residues displayed different behaviors with a change in pH, which
might explain the differing result.</p></fn><fn id="tbl1-fn1"><label>b</label><p>Not determined.</p></fn></table-wrap-foot></table-wrap><p>To determine whether this is a common function of conserved proline
residues in IDPs, we investigated the interaction between the disordered
transactivation domain of MLL and the folded KIX domain of CBP (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Single (P2858A)
and double (P2846/2858A) PtoA mutants were made for MLL (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S1</ext-link>). Hereafter, these MLL mutations are
referenced to the peptide investigated in this study (P9A and P9/21A).</p><p>Using circular dichroism spectroscopy (CD), an increase in helicity
upon PtoA mutation was observed (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S2A</ext-link>), consistent with both the previous p53 data<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> and the idea that helix-flanking prolines control the level of residual
helical structure.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Such an observation
might be due to a simple extension of the helix or, as observed in
p53, to an increase in the stability of the helical region itself
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). To confirm and locate the changes in helicity,
MLL WT and P9/21A were investigated using NMR spectroscopy. As expected,
increases in helicity were observed at and around the site of the
mutation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B
and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S2B</ext-link>), with a 1.4-fold increase
in helicity observed within the region that becomes helical upon binding.
For MLL, mutation of the N-terminal helix-flanking proline increased
the helicity to an extent greater than that seen when the C-terminal
proline was mutated (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Helix-flanking prolines modulate residual structure in p53 and
MLL. Change in per residue fractional helicity estimates upon PtoA
mutation for (A) p53 P27A and (B) MLL P9/21A. WT residues that become
helical upon binding are underlined. Conserved helix-flanking prolines
are highlighted. p53 NMR helicity data are from ref (<xref ref-type="bibr" rid="ref3">3</xref>). Individual fractional
helicity plots for MLL WT and P9/21A are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S2B</ext-link>. Estimates from NMR and CD gave similar changes
in overall MLL helicity (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Note that the mean helicity within the region that becomes
helical upon binding was increased by 2.5-fold in p53 P27A and 1.4-fold
in MLL P9/21A, compared to that of the WT. Helix-flanking prolines
are shown as cyan spheres in the structures of (A) p53:MDM2 (PDB entry 1YCR) and (B) MLL:KIX
(PDB entry 2LXS). Cyan circles represent helix-flanking prolines that are not present
in the structure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_0003" id="gr3" position="float"/></fig><p>Surprisingly, given the
1.4-fold increase in residual helicity,
equilibrium binding experiments demonstrated a large, approximate
25-fold, reduction in affinity for MLL P9/21A, compared to that of
the WT or P21A (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3A</ext-link>). MLL, therefore, does
not fit the prevailing view that an increase in the level of residual
structure enhances binding affinity.<sup><xref ref-type="bibr" rid="ref3">3</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> To determine the cause
of these unexpected changes, we turned again to the reaction kinetics.
As for the p53:MDM2 interaction, the association rate constant was
almost unaffected in our PtoA mutants [a &#x0003c;1.2 &#x000b1; 0.6-fold decrease
in <italic>k</italic><sub>on</sub> was observed for both MLL mutants
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3B</ext-link>)]. Again, the change in affinity for
MLL P9/21A was almost entirely due to changes in <italic>k</italic><sub>off</sub> (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3C</ext-link>). This observation has been made previously
in mutagenesis studies of other peptides that form simple helices
upon binding,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> and is consistent with
an induced fit mechanism of binding. We note that the error in <italic>k</italic><sub>on</sub> is large because of the difficulty in collecting
the data;<xref rid="fn1" ref-type="fn">a</xref> however, determining <italic>k</italic><sub>on</sub> by dividing <italic>k</italic><sub>off</sub> by <italic>K</italic><sub>d</sub> gave a similar 2 &#x000b1; 0.3-fold decrease
in <italic>k</italic><sub>on</sub> for MLL P9/21A.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Fold change in thermodynamic
and kinetic parameters upon mutation. <italic>k</italic><sub>on</sub> not determined for MLL L8A. <italic>K</italic><sub>d</sub> error
bars represent the standard error of the mean
(SEM; <italic>n</italic> = 3). Error bars for <italic>k</italic><sub>on</sub> and <italic>k</italic><sub>off</sub> represent the error
of the fit, except for MLL P9/21A and MLL L8A, where error bars represent
the SEM (<italic>n</italic> = 7 and 5, respectively).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2017-00179h_0004" id="gr4" position="float"/></fig><p>What causes the unexpected 25-fold reduction in
affinity of MLL
for KIX upon mutation of Pro9 to Ala? Like any other mutation, the
PtoA mutation has the potential to remove interactions of the MLL
proline side chain with KIX, which could explain the decrease in affinity.
However, compared to those of WT and P21A:KIX, we had noticed a change
in the maximal anisotropy of the MLL P9/21A:KIX complex (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3A</ext-link>), and CD indicated that there was
an increase in helicity within the bound complex (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S4A</ext-link>). We thus examined the bound structure. Immediately
N-terminal of P9, a leucine (L8) of MLL packs into a hydrophobic pocket
of KIX<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S4B</ext-link>). Proline residues are known to influence the conformation of preceding
residues,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> so perhaps mutation of P9A
could be indirectly disrupting the interaction of L8A with KIX. To
test our hypothesis, we mutated L8, which we reasoned should lead
to similar changes in affinity. Accordingly, mutation of L8 to Ala
decreased the affinity for KIX approximately 53-fold (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3A</ext-link>). Again, the decrease was predominantly explained by an increase
in <italic>k</italic><sub>off</sub> (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>, and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">Figure S3C</ext-link>). We note
that the 13.9 &#x000b1; 0.6-fold shift in <italic>k</italic><sub>off</sub> for the MLL L8A mutants accounts for the majority of the 15.8 &#x000b1;
0.5-fold change in <italic>k</italic><sub>off</sub> observed for MLL
P9A. This indicates that the disruption of the interaction of L8 with
KIX is the predominant reason for the decrease in affinity upon P9A
mutation, rather than a loss of proline side chain interactions.</p></sec><sec id="sec4"><title>Conclusions</title><p>In contrast to the suggestion that their role is to determine the
population of structures in a binding competent state,<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> we find that conserved IDR helix-flanking prolines control affinity
by modulating the lifetime of the bound complex. Therefore, while
helix-flanking prolines may reduce the level of residual free IDP/IDR
helical structure, any influence on affinity occurs predominantly
through effects in the bound state of the IDP/IDR:target complex.
Remarkably, mutation of helix-flanking prolines to alanines was not
always associated with an increase in affinity, as a significant decrease
was observed for MLL:KIX. Control of IDP/IDR:target binding affinity
is crucial for cellular function.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Clearly,
evolution can result in helix-flanking prolines being conserved to
allow subtle, system specific, ways of controlling the affinity and
lifetime of important regulatory complexes.</p></sec></body><back><notes id="notes-2" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b00179">10.1021/acs.biochem.7b00179</ext-link>.<list id="silist" list-type="simple"><list-item><p>Materials and
methods used for protein expression, purification
and labeling, circular dichroism, and equilibrium binding experiments;
peptide and protein sequences used in this investigation (Figure S1);
CD and NMR data for MLL mutants (Figure S2); thermodynamic and kinetic
characterization of MLL mutants (Figure S3); and structural comparison
of MLL WT:KIX and MLL P9/21A:KIX complexes (Figure S4) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biochem.7b00179/suppl_file/bi7b00179_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi7b00179_si_001.pdf"><caption><p>bi7b00179_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes-1"><title>Author Present Address</title><p><sup>&#x02225;</sup> S.L.S.:
Department of Biochemistry, University of Oxford, Oxford
OX1 3QU, U.K.</p></notes><notes notes-type="funding-statement" id="notes-3"><p>This work was
supported by the Wellcome Trust (WT 095195MA). J.C. is a Wellcome
Trust Senior Research Fellow. M.D.C. is supported by a Biotechnology
and Biological Sciences Research Council (BBSRC) studentship. G.W.D.
is supported by the National Institutes of Health (2R01CA14124406-A1
and 1R01GM115556-01A1).</p></notes><notes notes-type="COI-statement" id="NOTES-d165e1395-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><fn-group><fn id="fn1"><label>a</label><p>The small amount of complex formation
(high <italic>K</italic><sub>d</sub>), combined with the approximate
25-fold increase in <italic>k</italic><sub>off</sub> for MLL P9/21A,
meant the kinetic traces for this mutant were short, with only small
signal changes. It is challenging to extract consistent rates under
these conditions, which are at the limit of operation of our stopped-flow
apparatus. To address this issue, we developed a new fitting strategy,
which is described in detail in Materials and Methods.</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Dyson</surname><given-names>H. J.</given-names></name>; <name><surname>Wright</surname><given-names>P. E.</given-names></name> (<year>2005</year>) <article-title>Intrinsically unstructured
proteins and their functions</article-title>. <source>Nat. Rev. Mol.
Cell Biol.</source>
<volume>6</volume>, <fpage>197</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1589</pub-id>.<pub-id pub-id-type="pmid">15738986</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Dyson</surname><given-names>H. J.</given-names></name>; <name><surname>Wright</surname><given-names>P. E.</given-names></name> (<year>2002</year>) <article-title>Coupling of folding
and binding for unstructured proteins</article-title>. <source>Curr.
Opin. Struct. Biol.</source>
<volume>12</volume>, <fpage>54</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0959-440X(02)00289-0</pub-id>.<pub-id pub-id-type="pmid">11839490</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Borcherds</surname><given-names>W.</given-names></name>; <name><surname>Theillet</surname><given-names>F.-X.</given-names></name>; <name><surname>Katzer</surname><given-names>A.</given-names></name>; <name><surname>Finzel</surname><given-names>A.</given-names></name>; <name><surname>Mishall</surname><given-names>K. M.</given-names></name>; <name><surname>Powell</surname><given-names>A. T.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Manieri</surname><given-names>W.</given-names></name>; <name><surname>Dieterich</surname><given-names>C.</given-names></name>; <name><surname>Selenko</surname><given-names>P.</given-names></name>; <name><surname>Loewer</surname><given-names>A.</given-names></name>; <name><surname>Daughdrill</surname><given-names>G. W.</given-names></name> (<year>2014</year>) <article-title>Disorder
and residual helicity alter p53-Mdm2 binding affinity and signaling
in cells</article-title>. <source>Nat. Chem. Biol.</source>
<volume>10</volume>, <fpage>1000</fpage>&#x02013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1668</pub-id>.<pub-id pub-id-type="pmid">25362358</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Krieger</surname><given-names>J. M.</given-names></name>; <name><surname>Fusco</surname><given-names>G.</given-names></name>; <name><surname>Lewitzky</surname><given-names>M.</given-names></name>; <name><surname>Simister</surname><given-names>P. C.</given-names></name>; <name><surname>Marchant</surname><given-names>J.</given-names></name>; <name><surname>Camilloni</surname><given-names>C.</given-names></name>; <name><surname>Feller</surname><given-names>S. M.</given-names></name>; <name><surname>De Simone</surname><given-names>A.</given-names></name> (<year>2014</year>) <article-title>Conformational
recognition of an intrinsically disordered protein</article-title>. <source>Biophys. J.</source>
<volume>106</volume>, <fpage>1771</fpage>&#x02013;<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2014.03.004</pub-id>.<pub-id pub-id-type="pmid">24739176</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Ie&#x00161;mantavi&#x0010d;ius</surname><given-names>V.</given-names></name>; <name><surname>Dogan</surname><given-names>J.</given-names></name>; <name><surname>Jemth</surname><given-names>P.</given-names></name>; <name><surname>Teilum</surname><given-names>K.</given-names></name>; <name><surname>Kjaergaard</surname><given-names>M.</given-names></name> (<year>2014</year>) <article-title>Helical propensity
in an intrinsically disordered protein accelerates ligand binding</article-title>. <source>Angew. Chem., Int. Ed.</source>
<volume>53</volume>, <fpage>1548</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201307712</pub-id>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Theillet</surname><given-names>F.-X.</given-names></name>; <name><surname>Kalmar</surname><given-names>L.</given-names></name>; <name><surname>Tompa</surname><given-names>P.</given-names></name>; <name><surname>Han</surname><given-names>K.-H.</given-names></name>; <name><surname>Selenko</surname><given-names>P.</given-names></name>; <name><surname>Dunker</surname><given-names>A. K.</given-names></name>; <name><surname>Daughdrill</surname><given-names>G. W.</given-names></name>; <name><surname>Uversky</surname><given-names>V. N.</given-names></name> (<year>2013</year>) <article-title>The alphabet of
intrinsic disorder</article-title>. <source>Intrinsically Disord. Proteins</source>
<volume>1</volume>, <fpage>e24360</fpage>&#x02013;<lpage>e24373</lpage>. <pub-id pub-id-type="doi">10.4161/idp.24360</pub-id>.<pub-id pub-id-type="pmid">28516008</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Lee</surname><given-names>C.</given-names></name>; <name><surname>Kalmar</surname><given-names>L.</given-names></name>; <name><surname>Xue</surname><given-names>B.</given-names></name>; <name><surname>Tompa</surname><given-names>P.</given-names></name>; <name><surname>Daughdrill</surname><given-names>G. W.</given-names></name>; <name><surname>Uversky</surname><given-names>V. N.</given-names></name>; <name><surname>Han</surname><given-names>K.-H.</given-names></name> (<year>2014</year>) <article-title>Contribution
of proline to the pre-structuring
tendency of transient helical secondary structure elements in intrinsically
disordered proteins</article-title>. <source>Biochim. Biophys. Acta,
Gen. Subj.</source>
<volume>1840</volume>, <fpage>993</fpage>&#x02013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.10.042</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Brown</surname><given-names>C. J.</given-names></name>; <name><surname>Johnson</surname><given-names>A. K.</given-names></name>; <name><surname>Dunker</surname><given-names>A. K.</given-names></name>; <name><surname>Daughdrill</surname><given-names>G. W.</given-names></name> (<year>2011</year>) <article-title>Evolution
and disorder</article-title>. <source>Curr. Opin. Struct. Biol.</source>
<volume>21</volume>, <fpage>441</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2011.02.005</pub-id>.<pub-id pub-id-type="pmid">21482101</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Shammas</surname><given-names>S. L.</given-names></name>; <name><surname>Crabtree</surname><given-names>M. D.</given-names></name>; <name><surname>Dahal</surname><given-names>L.</given-names></name>; <name><surname>Wicky</surname><given-names>B. I. M.</given-names></name>; <name><surname>Clarke</surname><given-names>J.</given-names></name> (<year>2016</year>) <article-title>Insights into
coupled folding and binding mechanisms from kinetic studies</article-title>. <source>J. Biol. Chem.</source>
<volume>291</volume>, <fpage>6689</fpage>&#x02013;<lpage>6695</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R115.692715</pub-id>.<pub-id pub-id-type="pmid">26851275</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Gianni</surname><given-names>S.</given-names></name>; <name><surname>Dogan</surname><given-names>J.</given-names></name>; <name><surname>Jemth</surname><given-names>P.</given-names></name> (<year>2014</year>) <article-title>Distinguishing induced fit from conformational
selection</article-title>. <source>Biophys. Chem.</source>
<volume>189</volume>, <fpage>33</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpc.2014.03.003</pub-id>.<pub-id pub-id-type="pmid">24747333</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Goujon</surname><given-names>M.</given-names></name>; <name><surname>McWilliam</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Valentin</surname><given-names>F.</given-names></name>; <name><surname>Squizzato</surname><given-names>S.</given-names></name>; <name><surname>Paern</surname><given-names>J.</given-names></name>; <name><surname>Lopez</surname><given-names>R.</given-names></name> (<year>2010</year>) <article-title>A new bioinformatics
analysis tools
framework at EMBL-EBI</article-title>. <source>Nucleic Acids Res.</source>
<volume>38</volume>, <fpage>W695</fpage>&#x02013;<lpage>W699</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq313</pub-id>.<pub-id pub-id-type="pmid">20439314</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Sievers</surname><given-names>F.</given-names></name>; <name><surname>Wilm</surname><given-names>A.</given-names></name>; <name><surname>Dineen</surname><given-names>D.</given-names></name>; <name><surname>Gibson</surname><given-names>T. J.</given-names></name>; <name><surname>Karplus</surname><given-names>K.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Lopez</surname><given-names>R.</given-names></name>; <name><surname>McWilliam</surname><given-names>H.</given-names></name>; <name><surname>Remmert</surname><given-names>M.</given-names></name>; <name><surname>Soding</surname><given-names>J.</given-names></name>; <name><surname>Thompson</surname><given-names>J. D.</given-names></name>; <name><surname>Higgins</surname><given-names>D. G.</given-names></name>; <name><surname>Aniba</surname><given-names>M.</given-names></name>; <name><surname>Poch</surname><given-names>O.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Blackshields</surname><given-names>G.</given-names></name>; <name><surname>Sievers</surname><given-names>F.</given-names></name>; <name><surname>Shi</surname><given-names>W.</given-names></name>; <name><surname>Wilm</surname><given-names>A.</given-names></name>; <name><surname>Higgins</surname><given-names>D.</given-names></name>; <name><surname>Bradley</surname><given-names>R.</given-names></name>; <name><surname>Roberts</surname><given-names>A.</given-names></name>; <name><surname>Smoot</surname><given-names>M.</given-names></name>; <name><surname>Juvekar</surname><given-names>S.</given-names></name>; <name><surname>Do</surname><given-names>J.</given-names></name>; <name><surname>Dewey</surname><given-names>C.</given-names></name>; <name><surname>Holmes</surname><given-names>I.</given-names></name>; <name><surname>Pachter</surname><given-names>L.</given-names></name>; <name><surname>Clamp</surname><given-names>M.</given-names></name>; <name><surname>Cuff</surname><given-names>J.</given-names></name>; <name><surname>Searle</surname><given-names>S.</given-names></name>; <name><surname>Barton</surname><given-names>G.</given-names></name>; <name><surname>Do</surname><given-names>C.</given-names></name>; <name><surname>Mahabhashyam</surname><given-names>M.</given-names></name>; <name><surname>Brudno</surname><given-names>M.</given-names></name>; <name><surname>Batzoglou</surname><given-names>S.</given-names></name>; <name><surname>Eddy</surname><given-names>S.</given-names></name>; <name><surname>Edgar</surname><given-names>R.</given-names></name>; <name><surname>Edgar</surname><given-names>R.</given-names></name>; <name><surname>Finn</surname><given-names>R.</given-names></name>; <name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Tate</surname><given-names>J.</given-names></name>; <name><surname>Coggill</surname><given-names>P.</given-names></name>; <name><surname>Heger</surname><given-names>A.</given-names></name>; <name><surname>Pollington</surname><given-names>J.</given-names></name>; <name><surname>Gavin</surname><given-names>O.</given-names></name>; <name><surname>Gunasekaran</surname><given-names>P.</given-names></name>; <name><surname>Ceric</surname><given-names>G.</given-names></name>; <name><surname>Forslund</surname><given-names>K.</given-names></name>; <name><surname>Holm</surname><given-names>L.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E.</given-names></name>; <name><surname>Eddy</surname><given-names>S.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Gouy</surname><given-names>M.</given-names></name>; <name><surname>Guindon</surname><given-names>S.</given-names></name>; <name><surname>Gascuel</surname><given-names>O.</given-names></name>; <name><surname>Hogeweg</surname><given-names>P.</given-names></name>; <name><surname>Hesper</surname><given-names>B.</given-names></name>; <name><surname>Katoh</surname><given-names>K.</given-names></name>; <name><surname>Misawa</surname><given-names>K.</given-names></name>; <name><surname>Kuma</surname><given-names>K.</given-names></name>; <name><surname>Miyata</surname><given-names>T.</given-names></name>; <name><surname>Katoh</surname><given-names>K.</given-names></name>; <name><surname>Toh</surname><given-names>H.</given-names></name>; <name><surname>Larkin</surname><given-names>M.</given-names></name>; <name><surname>Blackshields</surname><given-names>G.</given-names></name>; <name><surname>Brown</surname><given-names>N.</given-names></name>; <name><surname>Chenna</surname><given-names>R.</given-names></name>; <name><surname>McGettigan</surname><given-names>P.</given-names></name>; <name><surname>McWilliam</surname><given-names>H.</given-names></name>; <name><surname>Valentin</surname><given-names>F.</given-names></name>; <name><surname>Wallace</surname><given-names>I.</given-names></name>; <name><surname>Wilm</surname><given-names>A.</given-names></name>; <name><surname>Lopez</surname><given-names>R.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Gibson</surname><given-names>T.</given-names></name>; <name><surname>Higgins</surname><given-names>D.</given-names></name>; <name><surname>Lassmann</surname><given-names>T.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Schmidt</surname><given-names>B.</given-names></name>; <name><surname>Maskell</surname><given-names>D.</given-names></name>; <name><surname>L&#x000f6;ytynoja</surname><given-names>A.</given-names></name>; <name><surname>Goldman</surname><given-names>N.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name>; <name><surname>Deane</surname><given-names>C.</given-names></name>; <name><surname>Blundell</surname><given-names>T.</given-names></name>; <name><surname>Overington</surname><given-names>J.</given-names></name>; <name><surname>Morgenstern</surname><given-names>B.</given-names></name>; <name><surname>Frech</surname><given-names>K.</given-names></name>; <name><surname>Dress</surname><given-names>A.</given-names></name>; <name><surname>Werner</surname><given-names>T.</given-names></name>; <name><surname>Notredame</surname><given-names>C.</given-names></name>; <name><surname>Higgins</surname><given-names>D.</given-names></name>; <name><surname>Heringa</surname><given-names>J.</given-names></name>; <name><surname>Pirovano</surname><given-names>W.</given-names></name>; <name><surname>Feenstra</surname><given-names>K.</given-names></name>; <name><surname>Heringa</surname><given-names>J.</given-names></name>; <name><surname>S&#x000f6;ding</surname><given-names>J.</given-names></name>; <name><surname>Thompson</surname><given-names>J.</given-names></name>; <name><surname>Koehl</surname><given-names>P.</given-names></name>; <name><surname>Ripp</surname><given-names>R.</given-names></name>; <name><surname>Poch</surname><given-names>O.</given-names></name>; <name><surname>Wilm</surname><given-names>A.</given-names></name>; <name><surname>Higgins</surname><given-names>D.</given-names></name>; <name><surname>Notredame</surname><given-names>C.</given-names></name> (<year>2014</year>) <article-title>Fast, scalable
generation of high-quality protein multiple sequence alignments using
Clustal Omega</article-title>. <source>Mol. Syst. Biol.</source>
<volume>7</volume>, <fpage>539</fpage><pub-id pub-id-type="doi">10.1038/msb.2011.75</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Kay</surname><given-names>L. E.</given-names></name>; <name><surname>Keifer</surname><given-names>P.</given-names></name>; <name><surname>Saarinen</surname><given-names>T.</given-names></name> (<year>1992</year>) <article-title>Pure Absorption Gradient Enhanced
Heteronuclear Single Quantum Correlation Spectroscopy with Improved
Sensitivity</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>114</volume>, <fpage>10663</fpage>&#x02013;<lpage>10665</lpage>. <pub-id pub-id-type="doi">10.1021/ja00052a088</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Muhandiram</surname><given-names>D. R.</given-names></name>; <name><surname>Kay</surname><given-names>L. E.</given-names></name> (<year>1994</year>) <article-title>Gradient-enhanced
triple-resonance three-dimensional
NMR experiments with improved sensitivity</article-title>. <source>J.
Magn. Reson., Ser. B</source>
<volume>103</volume>, <fpage>203</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1006/jmrb.1994.1032</pub-id>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Wittekind</surname><given-names>M.</given-names></name>; <name><surname>Mueller</surname><given-names>L.</given-names></name> (<year>1993</year>) <article-title>HNCACB, a high-sensitivity 3D NMR experiment to correlate
amide-proton and nitrogen resonances with the alpha- and beta-carbon
resonances in proteins</article-title>. <source>J. Magn. Reson., Ser.
B</source>
<volume>101</volume>, <fpage>201</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1006/jmrb.1993.1033</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Johnson</surname><given-names>B. A.</given-names></name> (<year>2004</year>) <article-title>Using NMRView
to visualize and analyze the NMR spectra of macromolecules</article-title>. <source>Methods Mol. Biol.</source>
<volume>278</volume>, <fpage>313</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1385/1-59259-809-9:313</pub-id>.<pub-id pub-id-type="pmid">15318002</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Johnson</surname><given-names>B. A.</given-names></name>; <name><surname>Blevins</surname><given-names>R. A.</given-names></name> (<year>1994</year>) <article-title>NMR View: A computer program for
the visualization
and analysis of NMR data</article-title>. <source>J. Biomol. NMR</source>
<volume>4</volume>, <fpage>603</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1007/BF00404272</pub-id>.<pub-id pub-id-type="pmid">22911360</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Markley</surname><given-names>J. L.</given-names></name>; <name><surname>Bax</surname><given-names>a</given-names></name>; <name><surname>Arata</surname><given-names>Y.</given-names></name>; <name><surname>Hilbers</surname><given-names>C. W.</given-names></name>; <name><surname>Kaptein</surname><given-names>R.</given-names></name>; <name><surname>Sykes</surname><given-names>B. D.</given-names></name>; <name><surname>Wright</surname><given-names>P. E.</given-names></name>; <name><surname>W&#x000fc;thrich</surname><given-names>K.</given-names></name> (<year>1998</year>) <article-title>Recommendations for the presentation
of NMR structures of proteins and nucleic acids--IUPAC-IUBMB-IUPAB
Inter-Union Task Group on the standardization of data bases of protein
and nucleic acid structures determined by NMR spectroscopy</article-title>. <source>Eur. J. Biochem.</source>
<volume>256</volume>, <fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.1998.2560001.x</pub-id>.<pub-id pub-id-type="pmid">9746340</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Tamiola</surname><given-names>K.</given-names></name>; <name><surname>Acar</surname><given-names>B.</given-names></name>; <name><surname>Mulder</surname><given-names>F. A. A.</given-names></name> (<year>2010</year>) <article-title>Sequence-specific
random coil chemical
shifts of intrinsically disordered proteins</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>132</volume>, <fpage>18000</fpage>&#x02013;<lpage>18003</lpage>. <pub-id pub-id-type="doi">10.1021/ja105656t</pub-id>.<pub-id pub-id-type="pmid">21128621</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Camilloni</surname><given-names>C.</given-names></name>; <name><surname>De Simone</surname><given-names>A.</given-names></name>; <name><surname>Vranken</surname><given-names>W. F.</given-names></name>; <name><surname>Vendruscolo</surname><given-names>M.</given-names></name> (<year>2012</year>) <article-title>Determination
of secondary structure populations in disordered states of proteins
using nuclear magnetic resonance chemical shifts</article-title>. <source>Biochemistry</source>
<volume>51</volume>, <fpage>2224</fpage>&#x02013;<lpage>2231</lpage>. <pub-id pub-id-type="doi">10.1021/bi3001825</pub-id>.<pub-id pub-id-type="pmid">22360139</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Shammas</surname><given-names>S.
L.</given-names></name>; <name><surname>Travis</surname><given-names>A. J.</given-names></name>; <name><surname>Clarke</surname><given-names>J.</given-names></name> (<year>2014</year>) <article-title>Allostery within a transcription
coactivator is predominantly mediated through dissociation rate constants</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>111</volume>, <fpage>12055</fpage>&#x02013;<lpage>12060</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1405815111</pub-id>.<pub-id pub-id-type="pmid">25092343</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Rogers</surname><given-names>J. M.</given-names></name>; <name><surname>Oleinikovas</surname><given-names>V.</given-names></name>; <name><surname>Shammas</surname><given-names>S. L.</given-names></name>; <name><surname>Wong</surname><given-names>C. T.</given-names></name>; <name><surname>De Sancho</surname><given-names>D.</given-names></name>; <name><surname>Baker</surname><given-names>C. M.</given-names></name>; <name><surname>Clarke</surname><given-names>J.</given-names></name> (<year>2014</year>) <article-title>Interplay between partner and ligand
facilitates the folding and binding of an intrinsically disordered
protein</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>111</volume>, <fpage>15420</fpage>&#x02013;<lpage>15425</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1409122111</pub-id>.<pub-id pub-id-type="pmid">25313042</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Toto</surname><given-names>A.</given-names></name>; <name><surname>Gianni</surname><given-names>S.</given-names></name> (<year>2016</year>) <article-title>Mutational analysis
of the binding-induced folding
reaction of the mixed-lineage leukemia protein to the KIX domain</article-title>. <source>Biochemistry</source>
<volume>55</volume>, <fpage>3957</fpage>&#x02013;<lpage>3962</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biochem.6b00505</pub-id>.<pub-id pub-id-type="pmid">27341615</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Rogers</surname><given-names>J. M.</given-names></name>; <name><surname>Wong</surname><given-names>C. T.</given-names></name>; <name><surname>Clarke</surname><given-names>J.</given-names></name> (<year>2014</year>) <article-title>Coupled folding and
binding of the
disordered protein PUMA does not require particular residual structure</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>136</volume>, <fpage>5197</fpage>&#x02013;<lpage>5200</lpage>. <pub-id pub-id-type="doi">10.1021/ja4125065</pub-id>.<pub-id pub-id-type="pmid">24654952</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Br&#x000fc;schweiler</surname><given-names>S.</given-names></name>; <name><surname>Konrat</surname><given-names>R.</given-names></name>; <name><surname>Tollinger</surname><given-names>M.</given-names></name> (<year>2013</year>) <article-title>Allosteric communication in the KIX
domain proceeds through dynamic repacking of the hydrophobic core</article-title>. <source>ACS Chem. Biol.</source>
<volume>8</volume>, <fpage>1600</fpage>&#x02013;<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1021/cb4002188</pub-id>.<pub-id pub-id-type="pmid">23651431</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>MacArthur</surname><given-names>M. W.</given-names></name>; <name><surname>Thornton</surname><given-names>J. M.</given-names></name> (<year>1991</year>) <article-title>Influence of proline residues on protein conformation</article-title>. <source>J. Mol. Biol.</source>
<volume>218</volume>, <fpage>397</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(91)90721-H</pub-id>.<pub-id pub-id-type="pmid">2010917</pub-id></mixed-citation></ref></ref-list></back></article>